Agilent Technologies (A) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Agilent Technologies

NYSE•Healthcare•Diagnostics & Research

$156.40+0.06(<0.01%)Market open

Market Cap

$44.09B

P/E

30.6x

P/S

6.0x

P/B

6.0x

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

How this company scores

ExcellentMetricSide Score: 85/100

Strongest: Profitability (25/25); weakest: Balance Sheet & Red Flags (16/25).

Profitability25/25

Growth21/25

Balance Sheet & Red Flags16/25

Cash & Earnings Quality23/25

Strengths

Rising free cash flowStrong marginsHigh ROERising earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 30.6x5y range 22.2x – 99.7x

Currently near its 20-quarter median.

P/S · 6.0x5y range 4.3x – 6.6x

Currently near its 20-quarter median.

P/B · 6.0x5y range 4.4x – 8.9x

Currently near its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $44.09B

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $7.37B
Q. Revenue: $1.88B
TTM EBITDA: $2.06B
TTM Op. Income: $1.64B
Q. Op. Income: $444.00M
TTM Net Income: $1.44B
Q. Net Income: $362.00M
EPS: $1.28
Shares Out.: $282.00M

$7.37B in TTM revenue grew 8.6% YoY, reaching $1.88B last quarter. TTM EBITDA of $2.06B and TTM operating income of $1.64B show growth is flowing through to the bottom line. TTM net income of $1.44B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 55.5%
EBITDA Margin: 27.2%
Op. Margin: 23.6%
Net Margin: 19.3%

Op. margin of 23.6% is up 2.9% YoY — cost efficiency is improving. Net margin at 19.3% and gross margin of 55.5% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 30.6x
P/S Ratio: 6.0x
P/B Ratio: 6.0x

At 30.6x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 6.0x and P/B of 6.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 11% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $13.97B
Cash: $1.76B
Long-Term Debt: $3.65B
Book Value: $7.36B
D/E Ratio: 0.5
Debt/EBITDA: 7.1

With $13.97B in assets and $3.65B in long-term debt, D/E is 0.5and book value is $7.36B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 6% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $519.00M
TTM Free Cash Flow: $1.27B
FCF Margin: 17.2%
FCF / Net Income: 0.9

TTM FCF of $1.27B on $519.00M in operating cash flow. The FCF / Net Income ratio of 0.9x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.